Zobrazeno 1 - 10
of 40
pro vyhledávání: '"D Pranger"'
Autor:
G. Cartron, MD, PhD, E. Bachy, MD, PhD, H. Tilly, MD, N. Daguindau, MD, G.-M. Pica, MD, F. Bijou, MD, C. Mounier, MD, A. M. Clavert, MD, G. L. Damaj, MD, PhD, B. Slama, MD, O. Casasnovas, MD, R. Houot, MD, PhD, K. Bouabdallah, MD, D. Sibon, MD, PhD, O. Fitoussi, MD, N. Morineau, MD, C. Herbaux, MD, PhD, T. Gastinne, MD, L.-M. Fornecker, MD, C. Haioun, MD, PhD, V. Launay, MD, C. Araujo, MD, O. Benbrahim, MD, L. Sanhes, MD, R. Gressin, MD, H. Gonzalez, MD, F. Morschhauser, MD, PhD, L. Xerri, MD, PhD, K. Tarte, PhD, D. Pranger, MD
Publikováno v:
HemaSphere, Vol 6, Pp 1023-1024 (2022)
Externí odkaz:
https://doaj.org/article/48271601dfa64751b35f88fd856e5e7b
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jan-Willem C. Alffenaar, Arianna D. Pranger, Mathieu S. Bolhuis, Jos G. W. Kosterink, Prashant N. Panday
Publikováno v:
Pharmaceutics, Vol 3, Iss 4, Pp 865-913 (2011)
Like any other drug, antimicrobial drugs are prone to pharmacokinetic drug interactions. These drug interactions are a major concern in clinical practice as they may have an effect on efficacy and toxicity. This article provides an overview of all pu
Externí odkaz:
https://doaj.org/article/6c64289edccb4fdd8ef0a82901b8982b
Publikováno v:
Drugs
The inability to use powerful antituberculosis drugs in an increasing number of patients seems to be the biggest threat towards global tuberculosis (TB) elimination. Simplified, shorter and preferably less toxic drug regimens are being investigated f
Autor:
Tom G. Jacobs, Arianna D. Pranger, Reinout van Crevel, Joost P.H. Drenth, Saye Khoo, David M. Burger
Publikováno v:
Aids, 33, 6, pp. 1097-1098
AIDS
Aids, 33, 1097-1098
AIDS
Aids, 33, 1097-1098
Contains fulltext : 202620.pdf (Publisher’s version ) (Closed access)
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 161
Since the introduction of the electronic e-cigarette a few years ago, its use has greatly increased. The liquid formulations used in these e-cigarettes contain nicotine in high concentrations; ingestion of these liquids can be fatal.A 42-year-old mal
Autor:
S Toffoli, S de Prophetis, A Konreich, Frédéric Lambert, P Mineur, D Pranger, D Sartenaer, Q Delefortrie, G Bulliard, M Jurdan, I Theate
Publikováno v:
Clinical Medical Reviews and Case Reports. 4
Autor:
Jos G. W. Kosterink, Noor Alsaad, Dick van Soolingen, Wiel C M de Lange, Arianna D. Pranger, Jan-Willem C. Alffenaar, Richard van Altena, Tjip S. van der Werf
Publikováno v:
European Respiratory Journal, 42, 504-12
European Respiratory Journal, 42, 2, pp. 504-12
European Respiratory Journal, 42(2), 504-512. EUROPEAN RESPIRATORY SOC JOURNALS LTD
European Respiratory Journal, 42, 2, pp. 504-12
European Respiratory Journal, 42(2), 504-512. EUROPEAN RESPIRATORY SOC JOURNALS LTD
Item does not contain fulltext Co-trimoxazole (SXT), a combination of sulfamethoxazole and trimethoprim, has shown in vitro activity against Mycobacterium tuberculosis. However, the pharmacokinetic and pharmacodynamic parameters of SXT in multidrug-r
Autor:
Jan-Willem C. Alffenaar, Arianna D. Pranger, Richard van Altena, Donald R. A. Uges, Tjip S. van der Werf, Rob E. Aarnoutse, Jos G. W. Kosterink
Publikováno v:
Therapeutic Drug Monitoring, 33, 3, pp. 350-4
Therapeutic Drug Monitoring, 33, 350-4
Therapeutic Drug Monitoring, 33(3), 350-354. LIPPINCOTT WILLIAMS & WILKINS
Therapeutic Drug Monitoring, 33, 350-4
Therapeutic Drug Monitoring, 33(3), 350-354. LIPPINCOTT WILLIAMS & WILKINS
Background: Moxifloxacin (MFX) is a potent drug for multidrug resistant tuberculosis(TB) treatment and is also useful if first-line agents are not tolerated. Therapeutic drug monitoring may help to prevent treatment failure. Obtaining a full concentr